A detailed history of Rbf Capital, LLC transactions in Enzo Biochem Inc stock. As of the latest transaction made, Rbf Capital, LLC holds 150,000 shares of ENZ stock, worth $82,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
150,000
Previous 250,359 40.09%
Holding current value
$82,500
Previous $92,000 10.87%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$0.26 - $0.55 $26,093 - $55,197
-100,359 Reduced 40.09%
150,000 $82,000
Q3 2021

Nov 15, 2021

SELL
$3.01 - $3.77 $40,794 - $51,094
-13,553 Reduced 5.14%
250,359 $886,000
Q2 2021

Aug 16, 2021

BUY
$2.86 - $3.61 $754,788 - $952,722
263,912 New
263,912 $837,000

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $26.8M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Rbf Capital, LLC Portfolio

Follow Rbf Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rbf Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rbf Capital, LLC with notifications on news.